The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Dapagliflozin 5mg

Dapagliflozin, a blood glucose lowering drug. Oral dose

DRUG

Dapagliflozin 10mg

Dapagliflozin, a blood glucose lowering drug. Oral dose

DRUG

Placebo tablet

Placebo tablet. Oral dose

Trial Locations (1)

Fukuoka